Nitrofurantoin plasma- and urine exposure in eight healthy beagle dogs following standard nitrofurantoin dosing regimen.
Antimicrobial
Canine
Cystitis
Pharmacokinetics
UTI
Journal
Research in veterinary science
ISSN: 1532-2661
Titre abrégé: Res Vet Sci
Pays: England
ID NLM: 0401300
Informations de publication
Date de publication:
20 Dec 2022
20 Dec 2022
Historique:
received:
03
06
2022
revised:
02
08
2022
accepted:
04
08
2022
pubmed:
17
8
2022
medline:
2
11
2022
entrez:
16
8
2022
Statut:
ppublish
Résumé
Bacterial cystitis is common in dogs and is usually treated with antibiotics. Nitrofurantoin is used for treatment of bacterial cystitis in humans and might provide a feasible treatment option in dogs. The aim of this study was to investigate the nitrofurantoin plasma concentration-time course and potential adverse effects in dogs. Nitrofurantoin (4.4-5.0 mg/kg) was administered orally to eight healthy beagles every 8 h for five days before repeated plasma and urine samples were collected. An additional four beagles served as untreated controls. The nitrofurantoin plasma and urine concentrations were measured using ultra high precision liquid chromatography coupled to tandem mass-spectrometry and further analysed using a non-compartmental pharmacokinetic model. In plasma, the median C
Identifiants
pubmed: 35973234
pii: S0034-5288(22)00236-3
doi: 10.1016/j.rvsc.2022.08.005
pii:
doi:
Substances chimiques
Nitrofurantoin
927AH8112L
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
150-155Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None of the authors have any conflicts of interests to report.